nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—FKBP1A—Cyclosporine—systemic lupus erythematosus	0.171	0.287	CbGbCtD
Sirolimus—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0372	0.0625	CbGbCtD
Sirolimus—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0282	0.0473	CbGbCtD
Sirolimus—CYP3A7—Dapsone—systemic lupus erythematosus	0.0252	0.0423	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0252	0.0423	CbGbCtD
Sirolimus—CYP3A5—Dapsone—systemic lupus erythematosus	0.0189	0.0317	CbGbCtD
Sirolimus—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0175	0.0294	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0175	0.0294	CbGbCtD
Sirolimus—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0165	0.0278	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0165	0.0278	CbGbCtD
Sirolimus—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0164	0.0275	CbGbCtD
Sirolimus—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0149	0.025	CbGbCtD
Sirolimus—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0141	0.0236	CbGbCtD
Sirolimus—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0131	0.0221	CbGbCtD
Sirolimus—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0124	0.0208	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.0109	0.0183	CbGbCtD
Sirolimus—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.0109	0.0183	CbGbCtD
Sirolimus—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0107	0.0179	CbGbCtD
Sirolimus—ABCB1—Betamethasone—systemic lupus erythematosus	0.00914	0.0153	CbGbCtD
Sirolimus—ABCB1—Prednisolone—systemic lupus erythematosus	0.00902	0.0151	CbGbCtD
Sirolimus—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00855	0.0144	CbGbCtD
Sirolimus—ABCB1—Prednisone—systemic lupus erythematosus	0.00852	0.0143	CbGbCtD
Sirolimus—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00842	0.0141	CbGbCtD
Sirolimus—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00817	0.0137	CbGbCtD
Sirolimus—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00807	0.0136	CbGbCtD
Sirolimus—CYP3A4—Dapsone—systemic lupus erythematosus	0.00736	0.0124	CbGbCtD
Sirolimus—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00638	0.0107	CbGbCtD
Sirolimus—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00638	0.0107	CbGbCtD
Sirolimus—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00548	0.0092	CbGbCtD
Sirolimus—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0054	0.00907	CbGbCtD
Sirolimus—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00532	0.00893	CbGbCtD
Sirolimus—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00512	0.0086	CbGbCtD
Sirolimus—CYP3A4—Prednisone—systemic lupus erythematosus	0.0051	0.00857	CbGbCtD
Sirolimus—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00484	0.00812	CbGbCtD
Sirolimus—ABCB1—Methotrexate—systemic lupus erythematosus	0.00427	0.00718	CbGbCtD
Sirolimus—EIF4E—connective tissue—systemic lupus erythematosus	0.00349	0.0597	CbGeAlD
Sirolimus—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00319	0.00535	CbGbCtD
Sirolimus—EIF4E—kidney—systemic lupus erythematosus	0.00297	0.0508	CbGeAlD
Sirolimus—EIF4E—lymphoid tissue—systemic lupus erythematosus	0.00255	0.0437	CbGeAlD
Sirolimus—MTOR—blood plasma—systemic lupus erythematosus	0.00254	0.0434	CbGeAlD
Sirolimus—FKBP1A—blood plasma—systemic lupus erythematosus	0.00228	0.039	CbGeAlD
Sirolimus—EIF4E—lung—systemic lupus erythematosus	0.00211	0.036	CbGeAlD
Sirolimus—EIF4E—nervous system—systemic lupus erythematosus	0.00195	0.0334	CbGeAlD
Sirolimus—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00194	0.0331	CbGeAlD
Sirolimus—EIF4E—central nervous system—systemic lupus erythematosus	0.00188	0.0321	CbGeAlD
Sirolimus—FGF2—tendon—systemic lupus erythematosus	0.00146	0.025	CbGeAlD
Sirolimus—CYP3A4—urine—systemic lupus erythematosus	0.00143	0.0244	CbGeAlD
Sirolimus—MTOR—connective tissue—systemic lupus erythematosus	0.00135	0.0231	CbGeAlD
Sirolimus—FGF2—lung—systemic lupus erythematosus	0.00128	0.022	CbGeAlD
Sirolimus—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00124	0.0212	CbGeAlD
Sirolimus—MTOR—skin of body—systemic lupus erythematosus	0.00122	0.0209	CbGeAlD
Sirolimus—FKBP1A—connective tissue—systemic lupus erythematosus	0.00121	0.0208	CbGeAlD
Sirolimus—MTOR—kidney—systemic lupus erythematosus	0.00115	0.0197	CbGeAlD
Sirolimus—FKBP1A—skin of body—systemic lupus erythematosus	0.0011	0.0188	CbGeAlD
Sirolimus—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00106	0.0181	CbGeAlD
Sirolimus—FKBP1A—kidney—systemic lupus erythematosus	0.00103	0.0177	CbGeAlD
Sirolimus—SLC47A1—nephron tubule—systemic lupus erythematosus	0.00101	0.0173	CbGeAlD
Sirolimus—FKBP1A—cortex of kidney—systemic lupus erythematosus	0.00101	0.0172	CbGeAlD
Sirolimus—CYP3A5—blood plasma—systemic lupus erythematosus	0.000994	0.017	CbGeAlD
Sirolimus—MTOR—lymphoid tissue—systemic lupus erythematosus	0.000988	0.0169	CbGeAlD
Sirolimus—MTOR—tendon—systemic lupus erythematosus	0.000928	0.0159	CbGeAlD
Sirolimus—MTOR—bone marrow—systemic lupus erythematosus	0.000899	0.0154	CbGeAlD
Sirolimus—SLC47A1—kidney—systemic lupus erythematosus	0.000889	0.0152	CbGeAlD
Sirolimus—FKBP1A—lymphoid tissue—systemic lupus erythematosus	0.000888	0.0152	CbGeAlD
Sirolimus—SLCO1B1—kidney—systemic lupus erythematosus	0.000877	0.015	CbGeAlD
Sirolimus—SLC47A1—cortex of kidney—systemic lupus erythematosus	0.000866	0.0148	CbGeAlD
Sirolimus—FKBP1A—tendon—systemic lupus erythematosus	0.000835	0.0143	CbGeAlD
Sirolimus—MTOR—lung—systemic lupus erythematosus	0.000815	0.0139	CbGeAlD
Sirolimus—FKBP1A—bone marrow—systemic lupus erythematosus	0.000809	0.0138	CbGeAlD
Sirolimus—MTOR—nervous system—systemic lupus erythematosus	0.000754	0.0129	CbGeAlD
Sirolimus—CYP3A4—blood plasma—systemic lupus erythematosus	0.000746	0.0128	CbGeAlD
Sirolimus—FKBP1A—lung—systemic lupus erythematosus	0.000733	0.0125	CbGeAlD
Sirolimus—MTOR—central nervous system—systemic lupus erythematosus	0.000726	0.0124	CbGeAlD
Sirolimus—SLC47A1—tendon—systemic lupus erythematosus	0.000718	0.0123	CbGeAlD
Sirolimus—FKBP1A—nervous system—systemic lupus erythematosus	0.000679	0.0116	CbGeAlD
Sirolimus—FKBP1A—central nervous system—systemic lupus erythematosus	0.000653	0.0112	CbGeAlD
Sirolimus—SLC47A1—lung—systemic lupus erythematosus	0.00063	0.0108	CbGeAlD
Sirolimus—SLC47A1—nervous system—systemic lupus erythematosus	0.000583	0.00997	CbGeAlD
Sirolimus—SLC47A1—central nervous system—systemic lupus erythematosus	0.000561	0.0096	CbGeAlD
Sirolimus—ABCB1—blood plasma—systemic lupus erythematosus	0.000528	0.00903	CbGeAlD
Sirolimus—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000512	0.00876	CbGeAlD
Sirolimus—CYP3A5—kidney—systemic lupus erythematosus	0.00045	0.0077	CbGeAlD
Sirolimus—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000439	0.0075	CbGeAlD
Sirolimus—CYP3A4—kidney—systemic lupus erythematosus	0.000338	0.00578	CbGeAlD
Sirolimus—CYP3A5—lung—systemic lupus erythematosus	0.000319	0.00546	CbGeAlD
Sirolimus—ABCB1—nephron tubule—systemic lupus erythematosus	0.000272	0.00466	CbGeAlD
Sirolimus—ABCB1—kidney—systemic lupus erythematosus	0.000239	0.00409	CbGeAlD
Sirolimus—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000233	0.00398	CbGeAlD
Sirolimus—CYP3A4—nervous system—systemic lupus erythematosus	0.000222	0.00379	CbGeAlD
Sirolimus—CYP3A4—central nervous system—systemic lupus erythematosus	0.000213	0.00365	CbGeAlD
Sirolimus—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000205	0.00351	CbGeAlD
Sirolimus—ABCB1—bone marrow—systemic lupus erythematosus	0.000187	0.0032	CbGeAlD
Sirolimus—ABCB1—lung—systemic lupus erythematosus	0.00017	0.0029	CbGeAlD
Sirolimus—ABCB1—nervous system—systemic lupus erythematosus	0.000157	0.00268	CbGeAlD
Sirolimus—ABCB1—central nervous system—systemic lupus erythematosus	0.000151	0.00258	CbGeAlD
Sirolimus—Myalgia—Betamethasone—systemic lupus erythematosus	5.15e-05	0.000225	CcSEcCtD
Sirolimus—Myalgia—Dexamethasone—systemic lupus erythematosus	5.15e-05	0.000225	CcSEcCtD
Sirolimus—Abdominal pain—Cyclosporine—systemic lupus erythematosus	5.14e-05	0.000225	CcSEcCtD
Sirolimus—Body temperature increased—Cyclosporine—systemic lupus erythematosus	5.14e-05	0.000225	CcSEcCtD
Sirolimus—Anxiety—Dexamethasone—systemic lupus erythematosus	5.13e-05	0.000225	CcSEcCtD
Sirolimus—Anxiety—Betamethasone—systemic lupus erythematosus	5.13e-05	0.000225	CcSEcCtD
Sirolimus—Discomfort—Dexamethasone—systemic lupus erythematosus	5.09e-05	0.000223	CcSEcCtD
Sirolimus—Discomfort—Betamethasone—systemic lupus erythematosus	5.09e-05	0.000223	CcSEcCtD
Sirolimus—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	5.08e-05	0.000223	CcSEcCtD
Sirolimus—Haemoglobin—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000223	CcSEcCtD
Sirolimus—Hypotension—Methylprednisolone—systemic lupus erythematosus	5.07e-05	0.000222	CcSEcCtD
Sirolimus—Pain—Prednisolone—systemic lupus erythematosus	5.06e-05	0.000222	CcSEcCtD
Sirolimus—Haemorrhage—Methotrexate—systemic lupus erythematosus	5.05e-05	0.000221	CcSEcCtD
Sirolimus—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	5.02e-05	0.00022	CcSEcCtD
Sirolimus—Pharyngitis—Methotrexate—systemic lupus erythematosus	5.02e-05	0.00022	CcSEcCtD
Sirolimus—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.01e-05	0.00022	CcSEcCtD
Sirolimus—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.01e-05	0.00022	CcSEcCtD
Sirolimus—Nausea—Leflunomide—systemic lupus erythematosus	5e-05	0.000219	CcSEcCtD
Sirolimus—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000219	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.99e-05	0.000218	CcSEcCtD
Sirolimus—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.95e-05	0.000217	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.95e-05	0.000217	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.94e-05	0.000217	CcSEcCtD
Sirolimus—Pain—Hydrocortisone—systemic lupus erythematosus	4.94e-05	0.000216	CcSEcCtD
Sirolimus—Oedema—Betamethasone—systemic lupus erythematosus	4.93e-05	0.000216	CcSEcCtD
Sirolimus—Oedema—Dexamethasone—systemic lupus erythematosus	4.93e-05	0.000216	CcSEcCtD
Sirolimus—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4.93e-05	0.000216	CcSEcCtD
Sirolimus—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4.93e-05	0.000216	CcSEcCtD
Sirolimus—Insomnia—Triamcinolone—systemic lupus erythematosus	4.92e-05	0.000215	CcSEcCtD
Sirolimus—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.91e-05	0.000215	CcSEcCtD
Sirolimus—Infection—Dexamethasone—systemic lupus erythematosus	4.9e-05	0.000215	CcSEcCtD
Sirolimus—Infection—Betamethasone—systemic lupus erythematosus	4.9e-05	0.000215	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.89e-05	0.000214	CcSEcCtD
Sirolimus—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.88e-05	0.000214	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.87e-05	0.000213	CcSEcCtD
Sirolimus—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.87e-05	0.000213	CcSEcCtD
Sirolimus—Visual impairment—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000213	CcSEcCtD
Sirolimus—Anaemia—Prednisone—systemic lupus erythematosus	4.87e-05	0.000213	CcSEcCtD
Sirolimus—Shock—Betamethasone—systemic lupus erythematosus	4.85e-05	0.000213	CcSEcCtD
Sirolimus—Shock—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.000213	CcSEcCtD
Sirolimus—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.85e-05	0.000212	CcSEcCtD
Sirolimus—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.84e-05	0.000212	CcSEcCtD
Sirolimus—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.84e-05	0.000212	CcSEcCtD
Sirolimus—Agitation—Prednisone—systemic lupus erythematosus	4.84e-05	0.000212	CcSEcCtD
Sirolimus—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.83e-05	0.000212	CcSEcCtD
Sirolimus—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.83e-05	0.000212	CcSEcCtD
Sirolimus—Tachycardia—Betamethasone—systemic lupus erythematosus	4.82e-05	0.000211	CcSEcCtD
Sirolimus—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.82e-05	0.000211	CcSEcCtD
Sirolimus—Angioedema—Prednisone—systemic lupus erythematosus	4.81e-05	0.000211	CcSEcCtD
Sirolimus—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.79e-05	0.00021	CcSEcCtD
Sirolimus—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.79e-05	0.00021	CcSEcCtD
Sirolimus—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.78e-05	0.000209	CcSEcCtD
Sirolimus—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.77e-05	0.000209	CcSEcCtD
Sirolimus—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.77e-05	0.000209	CcSEcCtD
Sirolimus—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.76e-05	0.000208	CcSEcCtD
Sirolimus—Malaise—Prednisone—systemic lupus erythematosus	4.75e-05	0.000208	CcSEcCtD
Sirolimus—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.72e-05	0.000207	CcSEcCtD
Sirolimus—Syncope—Prednisone—systemic lupus erythematosus	4.72e-05	0.000207	CcSEcCtD
Sirolimus—Tinnitus—Methotrexate—systemic lupus erythematosus	4.71e-05	0.000206	CcSEcCtD
Sirolimus—Anorexia—Dexamethasone—systemic lupus erythematosus	4.7e-05	0.000206	CcSEcCtD
Sirolimus—Anorexia—Betamethasone—systemic lupus erythematosus	4.7e-05	0.000206	CcSEcCtD
Sirolimus—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.69e-05	0.000206	CcSEcCtD
Sirolimus—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.67e-05	0.000205	CcSEcCtD
Sirolimus—Asthenia—Cyclosporine—systemic lupus erythematosus	4.66e-05	0.000204	CcSEcCtD
Sirolimus—Pain—Triamcinolone—systemic lupus erythematosus	4.65e-05	0.000204	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.63e-05	0.000203	CcSEcCtD
Sirolimus—Hypotension—Betamethasone—systemic lupus erythematosus	4.61e-05	0.000202	CcSEcCtD
Sirolimus—Hypotension—Dexamethasone—systemic lupus erythematosus	4.61e-05	0.000202	CcSEcCtD
Sirolimus—Pruritus—Cyclosporine—systemic lupus erythematosus	4.6e-05	0.000201	CcSEcCtD
Sirolimus—Angiopathy—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000201	CcSEcCtD
Sirolimus—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.57e-05	0.0002	CcSEcCtD
Sirolimus—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.57e-05	0.0002	CcSEcCtD
Sirolimus—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.57e-05	0.0002	CcSEcCtD
Sirolimus—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.56e-05	0.0002	CcSEcCtD
Sirolimus—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.55e-05	0.000199	CcSEcCtD
Sirolimus—Hypertension—Prednisone—systemic lupus erythematosus	4.55e-05	0.000199	CcSEcCtD
Sirolimus—Chills—Methotrexate—systemic lupus erythematosus	4.54e-05	0.000199	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.5e-05	0.000197	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.5e-05	0.000197	CcSEcCtD
Sirolimus—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.48e-05	0.000196	CcSEcCtD
Sirolimus—Arthralgia—Prednisone—systemic lupus erythematosus	4.48e-05	0.000196	CcSEcCtD
Sirolimus—Myalgia—Prednisone—systemic lupus erythematosus	4.48e-05	0.000196	CcSEcCtD
Sirolimus—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.48e-05	0.000196	CcSEcCtD
Sirolimus—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.47e-05	0.000196	CcSEcCtD
Sirolimus—Anxiety—Prednisone—systemic lupus erythematosus	4.47e-05	0.000196	CcSEcCtD
Sirolimus—Insomnia—Betamethasone—systemic lupus erythematosus	4.46e-05	0.000196	CcSEcCtD
Sirolimus—Insomnia—Dexamethasone—systemic lupus erythematosus	4.46e-05	0.000196	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.45e-05	0.000195	CcSEcCtD
Sirolimus—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.45e-05	0.000195	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.44e-05	0.000194	CcSEcCtD
Sirolimus—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.43e-05	0.000194	CcSEcCtD
Sirolimus—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.43e-05	0.000194	CcSEcCtD
Sirolimus—Discomfort—Prednisone—systemic lupus erythematosus	4.43e-05	0.000194	CcSEcCtD
Sirolimus—Malnutrition—Methotrexate—systemic lupus erythematosus	4.4e-05	0.000193	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.36e-05	0.000191	CcSEcCtD
Sirolimus—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.00019	CcSEcCtD
Sirolimus—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.34e-05	0.00019	CcSEcCtD
Sirolimus—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.34e-05	0.00019	CcSEcCtD
Sirolimus—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.3e-05	0.000188	CcSEcCtD
Sirolimus—Dizziness—Cyclosporine—systemic lupus erythematosus	4.3e-05	0.000188	CcSEcCtD
Sirolimus—Oedema—Prednisone—systemic lupus erythematosus	4.3e-05	0.000188	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisone—systemic lupus erythematosus	4.3e-05	0.000188	CcSEcCtD
Sirolimus—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.29e-05	0.000188	CcSEcCtD
Sirolimus—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.29e-05	0.000188	CcSEcCtD
Sirolimus—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.29e-05	0.000188	CcSEcCtD
Sirolimus—Infection—Prednisone—systemic lupus erythematosus	4.27e-05	0.000187	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.26e-05	0.000187	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.26e-05	0.000187	CcSEcCtD
Sirolimus—Back pain—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000186	CcSEcCtD
Sirolimus—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.25e-05	0.000186	CcSEcCtD
Sirolimus—Shock—Prednisone—systemic lupus erythematosus	4.23e-05	0.000185	CcSEcCtD
Sirolimus—Pain—Dexamethasone—systemic lupus erythematosus	4.22e-05	0.000185	CcSEcCtD
Sirolimus—Pain—Betamethasone—systemic lupus erythematosus	4.22e-05	0.000185	CcSEcCtD
Sirolimus—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.21e-05	0.000185	CcSEcCtD
Sirolimus—Tachycardia—Prednisone—systemic lupus erythematosus	4.19e-05	0.000184	CcSEcCtD
Sirolimus—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.19e-05	0.000184	CcSEcCtD
Sirolimus—Skin disorder—Prednisone—systemic lupus erythematosus	4.17e-05	0.000183	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.15e-05	0.000182	CcSEcCtD
Sirolimus—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.14e-05	0.000182	CcSEcCtD
Sirolimus—Vomiting—Cyclosporine—systemic lupus erythematosus	4.13e-05	0.000181	CcSEcCtD
Sirolimus—Rash—Cyclosporine—systemic lupus erythematosus	4.1e-05	0.000179	CcSEcCtD
Sirolimus—Anorexia—Prednisone—systemic lupus erythematosus	4.1e-05	0.000179	CcSEcCtD
Sirolimus—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.09e-05	0.000179	CcSEcCtD
Sirolimus—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.09e-05	0.000179	CcSEcCtD
Sirolimus—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.08e-05	0.000179	CcSEcCtD
Sirolimus—Headache—Cyclosporine—systemic lupus erythematosus	4.07e-05	0.000178	CcSEcCtD
Sirolimus—Anaemia—Methotrexate—systemic lupus erythematosus	4.07e-05	0.000178	CcSEcCtD
Sirolimus—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.07e-05	0.000178	CcSEcCtD
Sirolimus—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.000178	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.000177	CcSEcCtD
Sirolimus—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.03e-05	0.000177	CcSEcCtD
Sirolimus—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.03e-05	0.000177	CcSEcCtD
Sirolimus—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.01e-05	0.000176	CcSEcCtD
Sirolimus—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4e-05	0.000175	CcSEcCtD
Sirolimus—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4e-05	0.000175	CcSEcCtD
Sirolimus—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.99e-05	0.000175	CcSEcCtD
Sirolimus—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.97e-05	0.000174	CcSEcCtD
Sirolimus—Malaise—Methotrexate—systemic lupus erythematosus	3.97e-05	0.000174	CcSEcCtD
Sirolimus—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.95e-05	0.000173	CcSEcCtD
Sirolimus—Leukopenia—Methotrexate—systemic lupus erythematosus	3.94e-05	0.000173	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.91e-05	0.000172	CcSEcCtD
Sirolimus—Dizziness—Prednisolone—systemic lupus erythematosus	3.91e-05	0.000171	CcSEcCtD
Sirolimus—Asthenia—Triamcinolone—systemic lupus erythematosus	3.9e-05	0.000171	CcSEcCtD
Sirolimus—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.9e-05	0.000171	CcSEcCtD
Sirolimus—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.9e-05	0.000171	CcSEcCtD
Sirolimus—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.9e-05	0.000171	CcSEcCtD
Sirolimus—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.9e-05	0.000171	CcSEcCtD
Sirolimus—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.89e-05	0.000171	CcSEcCtD
Sirolimus—Insomnia—Prednisone—systemic lupus erythematosus	3.89e-05	0.00017	CcSEcCtD
Sirolimus—Nausea—Cyclosporine—systemic lupus erythematosus	3.86e-05	0.000169	CcSEcCtD
Sirolimus—Paraesthesia—Prednisone—systemic lupus erythematosus	3.86e-05	0.000169	CcSEcCtD
Sirolimus—Pruritus—Triamcinolone—systemic lupus erythematosus	3.85e-05	0.000169	CcSEcCtD
Sirolimus—Cough—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000168	CcSEcCtD
Sirolimus—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.84e-05	0.000168	CcSEcCtD
Sirolimus—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.82e-05	0.000167	CcSEcCtD
Sirolimus—Dyspepsia—Prednisone—systemic lupus erythematosus	3.78e-05	0.000166	CcSEcCtD
Sirolimus—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.77e-05	0.000165	CcSEcCtD
Sirolimus—Myalgia—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000164	CcSEcCtD
Sirolimus—Chest pain—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000164	CcSEcCtD
Sirolimus—Arthralgia—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000164	CcSEcCtD
Sirolimus—Decreased appetite—Prednisone—systemic lupus erythematosus	3.74e-05	0.000164	CcSEcCtD
Sirolimus—Rash—Prednisolone—systemic lupus erythematosus	3.73e-05	0.000163	CcSEcCtD
Sirolimus—Dermatitis—Prednisolone—systemic lupus erythematosus	3.72e-05	0.000163	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.72e-05	0.000163	CcSEcCtD
Sirolimus—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.71e-05	0.000163	CcSEcCtD
Sirolimus—Headache—Prednisolone—systemic lupus erythematosus	3.7e-05	0.000162	CcSEcCtD
Sirolimus—Discomfort—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000162	CcSEcCtD
Sirolimus—Constipation—Prednisone—systemic lupus erythematosus	3.67e-05	0.000161	CcSEcCtD
Sirolimus—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.67e-05	0.000161	CcSEcCtD
Sirolimus—Rash—Hydrocortisone—systemic lupus erythematosus	3.64e-05	0.00016	CcSEcCtD
Sirolimus—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.64e-05	0.000159	CcSEcCtD
Sirolimus—Confusional state—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000159	CcSEcCtD
Sirolimus—Headache—Hydrocortisone—systemic lupus erythematosus	3.62e-05	0.000158	CcSEcCtD
Sirolimus—Dizziness—Triamcinolone—systemic lupus erythematosus	3.6e-05	0.000158	CcSEcCtD
Sirolimus—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.59e-05	0.000157	CcSEcCtD
Sirolimus—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.59e-05	0.000157	CcSEcCtD
Sirolimus—Infection—Methotrexate—systemic lupus erythematosus	3.57e-05	0.000156	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.54e-05	0.000155	CcSEcCtD
Sirolimus—Asthenia—Betamethasone—systemic lupus erythematosus	3.54e-05	0.000155	CcSEcCtD
Sirolimus—Asthenia—Dexamethasone—systemic lupus erythematosus	3.54e-05	0.000155	CcSEcCtD
Sirolimus—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000154	CcSEcCtD
Sirolimus—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000154	CcSEcCtD
Sirolimus—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.51e-05	0.000154	CcSEcCtD
Sirolimus—Nausea—Prednisolone—systemic lupus erythematosus	3.51e-05	0.000154	CcSEcCtD
Sirolimus—Pruritus—Dexamethasone—systemic lupus erythematosus	3.49e-05	0.000153	CcSEcCtD
Sirolimus—Pruritus—Betamethasone—systemic lupus erythematosus	3.49e-05	0.000153	CcSEcCtD
Sirolimus—Skin disorder—Methotrexate—systemic lupus erythematosus	3.49e-05	0.000153	CcSEcCtD
Sirolimus—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.47e-05	0.000152	CcSEcCtD
Sirolimus—Vomiting—Triamcinolone—systemic lupus erythematosus	3.46e-05	0.000151	CcSEcCtD
Sirolimus—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.45e-05	0.000151	CcSEcCtD
Sirolimus—Nausea—Hydrocortisone—systemic lupus erythematosus	3.43e-05	0.00015	CcSEcCtD
Sirolimus—Rash—Triamcinolone—systemic lupus erythematosus	3.43e-05	0.00015	CcSEcCtD
Sirolimus—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.43e-05	0.00015	CcSEcCtD
Sirolimus—Anorexia—Methotrexate—systemic lupus erythematosus	3.42e-05	0.00015	CcSEcCtD
Sirolimus—Rash—Methylprednisolone—systemic lupus erythematosus	3.42e-05	0.00015	CcSEcCtD
Sirolimus—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.42e-05	0.00015	CcSEcCtD
Sirolimus—Headache—Triamcinolone—systemic lupus erythematosus	3.41e-05	0.000149	CcSEcCtD
Sirolimus—Headache—Methylprednisolone—systemic lupus erythematosus	3.4e-05	0.000149	CcSEcCtD
Sirolimus—Body temperature increased—Prednisone—systemic lupus erythematosus	3.4e-05	0.000149	CcSEcCtD
Sirolimus—Abdominal pain—Prednisone—systemic lupus erythematosus	3.4e-05	0.000149	CcSEcCtD
Sirolimus—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.38e-05	0.000148	CcSEcCtD
Sirolimus—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.38e-05	0.000148	CcSEcCtD
Sirolimus—Hypotension—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000147	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.27e-05	0.000143	CcSEcCtD
Sirolimus—Dizziness—Betamethasone—systemic lupus erythematosus	3.26e-05	0.000143	CcSEcCtD
Sirolimus—Dizziness—Dexamethasone—systemic lupus erythematosus	3.26e-05	0.000143	CcSEcCtD
Sirolimus—Insomnia—Methotrexate—systemic lupus erythematosus	3.25e-05	0.000142	CcSEcCtD
Sirolimus—Nausea—Triamcinolone—systemic lupus erythematosus	3.23e-05	0.000142	CcSEcCtD
Sirolimus—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.22e-05	0.000141	CcSEcCtD
Sirolimus—Nausea—Methylprednisolone—systemic lupus erythematosus	3.22e-05	0.000141	CcSEcCtD
Sirolimus—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.2e-05	0.00014	CcSEcCtD
Sirolimus—Somnolence—Methotrexate—systemic lupus erythematosus	3.19e-05	0.00014	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.17e-05	0.000139	CcSEcCtD
Sirolimus—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000138	CcSEcCtD
Sirolimus—Vomiting—Dexamethasone—systemic lupus erythematosus	3.14e-05	0.000137	CcSEcCtD
Sirolimus—Vomiting—Betamethasone—systemic lupus erythematosus	3.14e-05	0.000137	CcSEcCtD
Sirolimus—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.12e-05	0.000137	CcSEcCtD
Sirolimus—Rash—Betamethasone—systemic lupus erythematosus	3.11e-05	0.000136	CcSEcCtD
Sirolimus—Rash—Dexamethasone—systemic lupus erythematosus	3.11e-05	0.000136	CcSEcCtD
Sirolimus—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.11e-05	0.000136	CcSEcCtD
Sirolimus—Dermatitis—Betamethasone—systemic lupus erythematosus	3.11e-05	0.000136	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000136	CcSEcCtD
Sirolimus—Headache—Betamethasone—systemic lupus erythematosus	3.09e-05	0.000135	CcSEcCtD
Sirolimus—Headache—Dexamethasone—systemic lupus erythematosus	3.09e-05	0.000135	CcSEcCtD
Sirolimus—Asthenia—Prednisone—systemic lupus erythematosus	3.08e-05	0.000135	CcSEcCtD
Sirolimus—Pain—Methotrexate—systemic lupus erythematosus	3.07e-05	0.000135	CcSEcCtD
Sirolimus—Pruritus—Prednisone—systemic lupus erythematosus	3.04e-05	0.000133	CcSEcCtD
Sirolimus—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.96e-05	0.00013	CcSEcCtD
Sirolimus—Diarrhoea—Prednisone—systemic lupus erythematosus	2.94e-05	0.000129	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000129	CcSEcCtD
Sirolimus—Nausea—Dexamethasone—systemic lupus erythematosus	2.93e-05	0.000128	CcSEcCtD
Sirolimus—Nausea—Betamethasone—systemic lupus erythematosus	2.93e-05	0.000128	CcSEcCtD
Sirolimus—Dizziness—Prednisone—systemic lupus erythematosus	2.84e-05	0.000124	CcSEcCtD
Sirolimus—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000124	CcSEcCtD
Sirolimus—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000124	CcSEcCtD
Sirolimus—Vomiting—Prednisone—systemic lupus erythematosus	2.73e-05	0.00012	CcSEcCtD
Sirolimus—Rash—Prednisone—systemic lupus erythematosus	2.71e-05	0.000119	CcSEcCtD
Sirolimus—Dermatitis—Prednisone—systemic lupus erythematosus	2.71e-05	0.000119	CcSEcCtD
Sirolimus—Headache—Prednisone—systemic lupus erythematosus	2.69e-05	0.000118	CcSEcCtD
Sirolimus—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000116	CcSEcCtD
Sirolimus—Asthenia—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000113	CcSEcCtD
Sirolimus—Nausea—Prednisone—systemic lupus erythematosus	2.55e-05	0.000112	CcSEcCtD
Sirolimus—Pruritus—Methotrexate—systemic lupus erythematosus	2.54e-05	0.000111	CcSEcCtD
Sirolimus—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000108	CcSEcCtD
Sirolimus—Dizziness—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000104	CcSEcCtD
Sirolimus—Vomiting—Methotrexate—systemic lupus erythematosus	2.28e-05	0.0001	CcSEcCtD
Sirolimus—Rash—Methotrexate—systemic lupus erythematosus	2.26e-05	9.92e-05	CcSEcCtD
Sirolimus—Dermatitis—Methotrexate—systemic lupus erythematosus	2.26e-05	9.91e-05	CcSEcCtD
Sirolimus—Headache—Methotrexate—systemic lupus erythematosus	2.25e-05	9.86e-05	CcSEcCtD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	2.14e-05	0.000182	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—IL6—systemic lupus erythematosus	2.14e-05	0.000182	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	2.14e-05	0.000182	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL18—systemic lupus erythematosus	2.13e-05	0.000181	CbGpPWpGaD
Sirolimus—Nausea—Methotrexate—systemic lupus erythematosus	2.13e-05	9.34e-05	CcSEcCtD
Sirolimus—FGF2—Immune System—CD40LG—systemic lupus erythematosus	2.13e-05	0.00018	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	2.12e-05	0.00018	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—IL6—systemic lupus erythematosus	2.12e-05	0.00018	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	2.1e-05	0.000179	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD8A—systemic lupus erythematosus	2.1e-05	0.000178	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	2.09e-05	0.000178	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—IL6—systemic lupus erythematosus	2.09e-05	0.000178	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD4—systemic lupus erythematosus	2.07e-05	0.000176	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TLR9—systemic lupus erythematosus	2.06e-05	0.000175	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD40—systemic lupus erythematosus	2.06e-05	0.000175	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—systemic lupus erythematosus	2.04e-05	0.000174	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CDKN1B—systemic lupus erythematosus	2.04e-05	0.000173	CbGpPWpGaD
Sirolimus—FGF2—Immune System—JAK1—systemic lupus erythematosus	2.03e-05	0.000172	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTLA4—systemic lupus erythematosus	2.03e-05	0.000172	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HMGB1—systemic lupus erythematosus	2.03e-05	0.000172	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD80—systemic lupus erythematosus	2.01e-05	0.000171	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—P2RY12—systemic lupus erythematosus	2e-05	0.00017	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL2—systemic lupus erythematosus	2e-05	0.00017	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNA1—systemic lupus erythematosus	1.99e-05	0.000169	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD4—systemic lupus erythematosus	1.99e-05	0.000169	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—IL6—systemic lupus erythematosus	1.96e-05	0.000167	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	1.95e-05	0.000166	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CDKN1B—systemic lupus erythematosus	1.95e-05	0.000165	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RASGRP1—systemic lupus erythematosus	1.94e-05	0.000165	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—EP300—systemic lupus erythematosus	1.94e-05	0.000165	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD79A—systemic lupus erythematosus	1.93e-05	0.000164	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD80—systemic lupus erythematosus	1.93e-05	0.000164	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD80—systemic lupus erythematosus	1.93e-05	0.000164	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—F2—systemic lupus erythematosus	1.92e-05	0.000163	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	1.9e-05	0.000161	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2RA—systemic lupus erythematosus	1.89e-05	0.000161	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.89e-05	0.00016	CbGpPWpGaD
Sirolimus—MTOR—Disease—JUNB—systemic lupus erythematosus	1.89e-05	0.00016	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CDKN1A—systemic lupus erythematosus	1.88e-05	0.00016	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PRL—systemic lupus erythematosus	1.88e-05	0.00016	CbGpPWpGaD
Sirolimus—FGF2—Immune System—C3—systemic lupus erythematosus	1.88e-05	0.00016	CbGpPWpGaD
Sirolimus—FGF2—Disease—JAK1—systemic lupus erythematosus	1.87e-05	0.000159	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	1.87e-05	0.000159	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CSK—systemic lupus erythematosus	1.84e-05	0.000156	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CD80—systemic lupus erythematosus	1.84e-05	0.000156	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—VEGFA—systemic lupus erythematosus	1.83e-05	0.000156	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.81e-05	0.000154	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.8e-05	0.000153	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—EP300—systemic lupus erythematosus	1.79e-05	0.000152	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CRP—systemic lupus erythematosus	1.79e-05	0.000152	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DQA1—systemic lupus erythematosus	1.79e-05	0.000152	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—JUNB—systemic lupus erythematosus	1.78e-05	0.000151	CbGpPWpGaD
Sirolimus—FGF2—Disease—CCR5—systemic lupus erythematosus	1.77e-05	0.000151	CbGpPWpGaD
Sirolimus—MTOR—Disease—PRL—systemic lupus erythematosus	1.74e-05	0.000148	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—JAK1—systemic lupus erythematosus	1.73e-05	0.000147	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	1.73e-05	0.000147	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR4—systemic lupus erythematosus	1.71e-05	0.000145	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HLA-DRB1—systemic lupus erythematosus	1.71e-05	0.000145	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—EP300—systemic lupus erythematosus	1.71e-05	0.000145	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CCL2—systemic lupus erythematosus	1.71e-05	0.000145	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TYK2—systemic lupus erythematosus	1.7e-05	0.000144	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.69e-05	0.000144	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.69e-05	0.000143	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TGFB1—systemic lupus erythematosus	1.68e-05	0.000143	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.68e-05	0.000143	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LYN—systemic lupus erythematosus	1.67e-05	0.000142	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DQB1—systemic lupus erythematosus	1.67e-05	0.000142	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.64e-05	0.000139	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PRL—systemic lupus erythematosus	1.64e-05	0.000139	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCR5—systemic lupus erythematosus	1.64e-05	0.000139	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TYK2—systemic lupus erythematosus	1.63e-05	0.000138	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.62e-05	0.000137	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—C3—systemic lupus erythematosus	1.6e-05	0.000136	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS3—systemic lupus erythematosus	1.6e-05	0.000136	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.59e-05	0.000135	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL18—systemic lupus erythematosus	1.58e-05	0.000134	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD80—systemic lupus erythematosus	1.58e-05	0.000134	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD40LG—systemic lupus erythematosus	1.58e-05	0.000134	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—systemic lupus erythematosus	1.57e-05	0.000134	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD8A—systemic lupus erythematosus	1.56e-05	0.000132	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—systemic lupus erythematosus	1.55e-05	0.000132	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TYK2—systemic lupus erythematosus	1.55e-05	0.000132	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD4—systemic lupus erythematosus	1.54e-05	0.000131	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NOS3—systemic lupus erythematosus	1.52e-05	0.000129	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.52e-05	0.000129	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.51e-05	0.000128	CbGpPWpGaD
Sirolimus—MTOR—Immune System—JAK1—systemic lupus erythematosus	1.51e-05	0.000128	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD4—systemic lupus erythematosus	1.48e-05	0.000125	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD4—systemic lupus erythematosus	1.47e-05	0.000125	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—systemic lupus erythematosus	1.46e-05	0.000124	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD80—systemic lupus erythematosus	1.46e-05	0.000124	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—systemic lupus erythematosus	1.46e-05	0.000124	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CDKN1B—systemic lupus erythematosus	1.45e-05	0.000123	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.44e-05	0.000123	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	1.41e-05	0.00012	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—F2—systemic lupus erythematosus	1.41e-05	0.000119	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2RA—systemic lupus erythematosus	1.41e-05	0.000119	CbGpPWpGaD
Sirolimus—MTOR—Immune System—C3—systemic lupus erythematosus	1.39e-05	0.000118	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.39e-05	0.000118	CbGpPWpGaD
Sirolimus—MTOR—Disease—JAK1—systemic lupus erythematosus	1.39e-05	0.000118	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	1.39e-05	0.000118	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CDKN1B—systemic lupus erythematosus	1.38e-05	0.000117	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CD80—systemic lupus erythematosus	1.35e-05	0.000115	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.35e-05	0.000114	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TYK2—systemic lupus erythematosus	1.33e-05	0.000113	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.33e-05	0.000113	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.33e-05	0.000113	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—systemic lupus erythematosus	1.33e-05	0.000113	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.32e-05	0.000112	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—JUNB—systemic lupus erythematosus	1.32e-05	0.000112	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.32e-05	0.000112	CbGpPWpGaD
Sirolimus—MTOR—Disease—CCR5—systemic lupus erythematosus	1.32e-05	0.000112	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—JAK1—systemic lupus erythematosus	1.31e-05	0.000111	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL2—systemic lupus erythematosus	1.29e-05	0.00011	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	1.28e-05	0.000109	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CDKN1A—systemic lupus erythematosus	1.28e-05	0.000108	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.27e-05	0.000108	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—systemic lupus erythematosus	1.27e-05	0.000108	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DRB1—systemic lupus erythematosus	1.27e-05	0.000108	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—EP300—systemic lupus erythematosus	1.27e-05	0.000108	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—systemic lupus erythematosus	1.27e-05	0.000108	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.25e-05	0.000107	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.25e-05	0.000106	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.25e-05	0.000106	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—systemic lupus erythematosus	1.25e-05	0.000106	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.24e-05	0.000106	CbGpPWpGaD
Sirolimus—FGF2—Disease—TYK2—systemic lupus erythematosus	1.23e-05	0.000105	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.22e-05	0.000104	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—systemic lupus erythematosus	1.22e-05	0.000104	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.22e-05	0.000103	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PRL—systemic lupus erythematosus	1.22e-05	0.000103	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—C3—systemic lupus erythematosus	1.21e-05	0.000103	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—EP300—systemic lupus erythematosus	1.21e-05	0.000103	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—systemic lupus erythematosus	1.21e-05	0.000103	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—systemic lupus erythematosus	1.21e-05	0.000103	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	1.19e-05	0.000101	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—systemic lupus erythematosus	1.17e-05	9.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD80—systemic lupus erythematosus	1.17e-05	9.96e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—EP300—systemic lupus erythematosus	1.16e-05	9.84e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.15e-05	9.77e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.14e-05	9.67e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CDKN1B—systemic lupus erythematosus	1.13e-05	9.64e-05	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—systemic lupus erythematosus	1.12e-05	9.52e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.12e-05	9.49e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—systemic lupus erythematosus	1.11e-05	9.46e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2—systemic lupus erythematosus	1.11e-05	9.43e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—systemic lupus erythematosus	1.11e-05	9.39e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.1e-05	9.38e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.1e-05	9.32e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	1.09e-05	9.28e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD80—systemic lupus erythematosus	1.08e-05	9.2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.07e-05	9.12e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—F2—systemic lupus erythematosus	1.07e-05	9.05e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.06e-05	9.03e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—systemic lupus erythematosus	1.06e-05	8.96e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CDKN1B—systemic lupus erythematosus	1.05e-05	8.9e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CDKN1A—systemic lupus erythematosus	1.05e-05	8.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CD80—systemic lupus erythematosus	1.02e-05	8.68e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.01e-05	8.56e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—EP300—systemic lupus erythematosus	9.97e-06	8.46e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TYK2—systemic lupus erythematosus	9.9e-06	8.41e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—JAK1—systemic lupus erythematosus	9.73e-06	8.26e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.68e-06	8.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CDKN1A—systemic lupus erythematosus	9.67e-06	8.21e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—systemic lupus erythematosus	9.5e-06	8.07e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2—systemic lupus erythematosus	9.47e-06	8.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—systemic lupus erythematosus	9.27e-06	7.88e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR5—systemic lupus erythematosus	9.22e-06	7.83e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—EP300—systemic lupus erythematosus	9.2e-06	7.81e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TYK2—systemic lupus erythematosus	9.14e-06	7.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2RA—systemic lupus erythematosus	9.09e-06	7.72e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—C3—systemic lupus erythematosus	9.01e-06	7.65e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—systemic lupus erythematosus	8.98e-06	7.62e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—systemic lupus erythematosus	8.97e-06	7.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—systemic lupus erythematosus	8.96e-06	7.61e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.93e-06	7.59e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TYK2—systemic lupus erythematosus	8.63e-06	7.33e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—EP300—systemic lupus erythematosus	8.5e-06	7.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—systemic lupus erythematosus	8.47e-06	7.19e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CDKN1B—systemic lupus erythematosus	8.42e-06	7.15e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—systemic lupus erythematosus	8.32e-06	7.06e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—systemic lupus erythematosus	8.27e-06	7.02e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2—systemic lupus erythematosus	8.24e-06	7e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—systemic lupus erythematosus	8.21e-06	6.97e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.05e-06	6.84e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—systemic lupus erythematosus	8e-06	6.79e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—systemic lupus erythematosus	7.95e-06	6.75e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—F2—systemic lupus erythematosus	7.91e-06	6.72e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	7.9e-06	6.71e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CDKN1B—systemic lupus erythematosus	7.78e-06	6.6e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CDKN1A—systemic lupus erythematosus	7.77e-06	6.6e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—systemic lupus erythematosus	7.59e-06	6.45e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CD80—systemic lupus erythematosus	7.59e-06	6.44e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	7.52e-06	6.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—EP300—systemic lupus erythematosus	7.4e-06	6.28e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.39e-06	6.28e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.34e-06	6.23e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.22e-06	6.13e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2—systemic lupus erythematosus	7.18e-06	6.1e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CDKN1A—systemic lupus erythematosus	7.18e-06	6.09e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—systemic lupus erythematosus	7.05e-06	5.99e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	6.9e-06	5.86e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—EP300—systemic lupus erythematosus	6.83e-06	5.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—systemic lupus erythematosus	6.8e-06	5.77e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.77e-06	5.75e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	6.76e-06	5.74e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	6.55e-06	5.56e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—systemic lupus erythematosus	6.53e-06	5.54e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	6.46e-06	5.49e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—EP300—systemic lupus erythematosus	6.44e-06	5.47e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TYK2—systemic lupus erythematosus	6.4e-06	5.44e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—systemic lupus erythematosus	6.29e-06	5.34e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	6.2e-06	5.27e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.1e-06	5.18e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—systemic lupus erythematosus	6.03e-06	5.12e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	5.96e-06	5.06e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—systemic lupus erythematosus	5.94e-06	5.04e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	5.93e-06	5.04e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	5.91e-06	5.02e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.6e-06	4.76e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—systemic lupus erythematosus	5.57e-06	4.73e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.44e-06	4.62e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	5.43e-06	4.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2—systemic lupus erythematosus	5.33e-06	4.53e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—systemic lupus erythematosus	5.04e-06	4.28e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.02e-06	4.27e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	4.99e-06	4.23e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	4.92e-06	4.18e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—systemic lupus erythematosus	4.84e-06	4.11e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—EP300—systemic lupus erythematosus	4.78e-06	4.06e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.53e-06	3.85e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	4.51e-06	3.83e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	4.48e-06	3.81e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—systemic lupus erythematosus	4.47e-06	3.8e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	4.29e-06	3.64e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—systemic lupus erythematosus	4.22e-06	3.58e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.16e-06	3.53e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	3.92e-06	3.33e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.76e-06	3.2e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.67e-06	3.12e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.38e-06	2.87e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	3.26e-06	2.77e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.24e-06	2.75e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—systemic lupus erythematosus	3.13e-06	2.66e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.96e-06	2.51e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.46e-06	2.09e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.32e-06	1.97e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.08e-06	1.77e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.99e-06	1.69e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.82e-06	1.55e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.52e-06	1.29e-05	CbGpPWpGaD
